Brazil's Anvisa Enjoys Industry Support Despite Regulatory Changes, Low Funding

Brazil's regulatory agency must now approve drug applications in specified timeframes, despite lack of resources; industry nevertheless sees a bright future for Anvisa and other agencies in region.